Filing Flows › Chemours (CC) › Q3 2026
Chemours (CC) Q3 2026 earnings results (third quarter 2026)
10-Q filed Nov 5, 2026
Chemours (CC) reported revenue of $1.5B for the third quarter 2026 (Q3 2026), +3% from a year earlier and -3% from the quarter before. Operating margin was 14.4%, net earnings $196M (12.7% of revenue).
Chemours, Q3 2026: revenue $1.5B (+3% year over year), operating margin 14.4%, net earnings $196M, operating cash flow $149M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5B | -3% | +3% |
| Gross profit | $231M | -19% | -0.9% |
| Operating profit | $222M | — | +484% |
| Net earnings | $196M | — | +326% |
| Operating cash flow | $149M | -6% | +2% |
| Free cash flow | $98.0M | -14% | -7% |
What changed
Revenue was $1.5B in Q3 2026, up 3% year over year and down 3% from the previous quarter. All Segments was the largest line at 99% of revenue. All Segments added $0.04B year over year (up 3%), 98% of the total change.
Gross margin was 15.0%, down 0.6 points from Q3 2025. Operating profit was $0.22B, a 14.4% margin (up 11.9 points year over year). Of the extra revenue versus Q3 2025, 409% reached operating profit, above the 3% margin then. Operating expenses fell 95% while revenue rose 3%. Net earnings were $0.20B, up 326% year over year. The effective tax rate was 11.7%.
Operating cash flow was $0.15B (up 2% year over year), 76% of net earnings. Non-cash charges added back $0.08B of depreciation and $4.0M of share-based compensation. Working capital and other items used $0.13B. Capital expenditures of $0.05B left free cash flow of $0.10B.
Questions
What was Chemours' revenue in the third quarter 2026?
Chemours (CC) reported revenue of $1.5B for the third quarter 2026 (Q3 2026), +3% from a year earlier and -3% from the quarter before.
Was Chemours profitable in the third quarter 2026?
Operating profit was $222M (14.4% of revenue) and net earnings $196M.
Source: Chemours 10-Q on SEC EDGAR.